Evidence map›Paper›PMID 30062211›Full record

ArticleJACC. Basic to translational science2018

Effects of Urocortin 2 Versus Urocortin 3 Gene Transfer on Left Ventricular Function and Glucose Disposal.

Dimosthenis Giamouridis, Mei Hua Gao, N Chin Lai, Zhen Tan, Young Chul Kim, Tracy Guo, Atsushi Miyanohara, W Matthijs Blankesteijn, Erik Biessen, H Kirk Hammond

Open access · goldAbstract read
In one paragraph

Article in JACC. Basic to translational science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Human gene therapy · 2022
    Article
  4. Article
  5. Article
  6. Review
  7. Molecular therapy. Methods & clinical development · 2020
    Article
  8. Review
  9. Urocortin 2 Gene Transfer Improves Heart Function in Aged Mice.Molecular therapy : the journal of the American Society of Gene Therapy · 2020
    Article
  10. Article
  11. Current Landscape of Heart Failure Gene Therapy.Journal of the American Heart Association · 2019
    Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Dimosthenis GiamouridisDepartment of Medicine, Veterans Affairs San Diego Healthcare System, San Diego, California.
Mei Hua GaoDepartment of Medicine, Veterans Affairs San Diego Healthcare System, San Diego, California.
N Chin LaiDepartment of Medicine, Veterans Affairs San Diego Healthcare System, San Diego, California.
Zhen TanDepartment of Medicine, Veterans Affairs San Diego Healthcare System, San Diego, California.
Young Chul KimDepartment of Medicine, Veterans Affairs San Diego Healthcare System, San Diego, California.
Tracy GuoDepartment of Medicine, Veterans Affairs San Diego Healthcare System, San Diego, California.
Atsushi MiyanoharaDepartment of Medicine, University of California San Diego, San Diego, California.
W Matthijs BlankesteijnDepartment of Pharmacology and Toxicology, Cardiovascular Research Institute Maastricht University, Maastricht, the Netherlands.
Erik BiessenDepartment of Pharmacology and Toxicology, Cardiovascular Research Institute Maastricht University, Maastricht, the Netherlands.
H Kirk HammondDepartment of Medicine, Veterans Affairs San Diego Healthcare System, San Diego, California.
University of California, San Diego · USVA San Diego Healthcare System · USMaastricht University · NL

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI David Mitchell Smith · 1994 to 2026
$78.4M
Vector Production CoreP01HL066941 · NHLBI · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI HAMMOND, H. KIRK · 2001 to 2017
$34.8M
Urocortin-2 Gene Transfer for CHF: a Paracrine Approach Using Intravenous AAV8R42HL122038 · NHLBI · RENOVA THERAPEUTICS, INC. · PI HAMMOND, H. KIRK · 2014 to 2017
$1.8M
Translational Studies of Paracrine CV Gene TransferI01BX001515 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI HAMMOND, H. KIRK · 2012 to 2015
–
Urocortin 2 Gene Transfer for Heart Failure with Preserved Ejection FractionI01BX003774 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI HAMMOND, H. KIRK · 2017 to 2025
–
BLRD VA I01 BX001515BLRD VA I01 BX003774NHLBI NIH HHS HHSN268201200041CNHLBI NIH HHS P01 HL066941NHLBI NIH HHS R42 HL122038NIAID NIH HHS P30 AI036214
6 · The paper itself

Abstract

UCn2 and UCn3 peptides have recently been infused to treat patients with heart failure (HF) but are limited by their short half-lives. A 1-time intravenous injection of virus vectors encoding UCn2 or UCn3 provided sustained increases in plasma concentrations of the peptides. This was associated with increases in both systolic and diastolic left ventricular (LV) function, mediated by increased LV SERCA2a expression and Ca

Indexed as

AAV, adeno-associated virusadeno-associated virusCaMKII, Ca2+/calmodulin-dependent protein kinase IIcAMP, 3′,5′-cyclic adenosine monophosphateCO, cardiac outputcontractile functionCRF, corticotropin-releasing factorCRHR, corticotropin-releasing hormone receptordiastolic functionEDD, end-diastolic diameterEF, ejection fractionESD, end-systolic diameterESPVR, end-systolic pressure-volume relationshipgc, genome copiesgene therapyHF, heart failureinsulin sensitivityIP, intraperitonealIV, intravenousLV, left ventricle/ventricularPKA, protein kinase ARYR2, ryanodine receptor 2SERCA2a, sarco/endoplasmic reticulum Ca2+-ATPaseTau, time constant of left ventricular pressure declineUCn2, urocortin 2UCn3, urocortin 3VCFc, velocity of circumferential fiber shortening corrected for heart rate

Identifiers

PMID30062211
PMCPMC6059348
OpenAlexW2802117731

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.